Conventional MR Imaging
Conventional MR imaging has a well-established role in the initial assessment of subjects with CIS. The risk of conversion to CDMS is greater in patients presenting with abnormal T2WI. Subjects with CIS subjects in the range of 50%-70% present with abnormal T2WI. 1 Two studies were identified which observed subjects for over 10 years. Fisniku et al 7 followed 107 subjects with CIS to 20.2 years; 82% with abnormal baseline MR imaging converted to CDMS, compared with 21% with normal MR imaging. In another study, 88% of subjects with abnormal MR imaging converted by 14 years, compared with 19% of those with normal scans. 6 T2 lesion number at presentation has been associated with increased risk of conversion to CDMS. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] However, a recent meta-analysis concluded that abnormal T2WI, regardless of lesion number, was associated with increased risk of conversion. 18 However, the review was limited, with nonuniform definitions of conversion to MS, and varied length of follow-up among the included studies.
In addition to T2 lesions, increased risk of conversion to MS is associated with the presence of gadolinium-enhancing lesions. 8, [12] [13] [14] 16, [19] [20] [21] [22] [23] Accurate estimation of the incidence of Gd-enhancing lesions at CIS presentation is difficult because of inconsistent administration of contrast across studies. Gd-enhancing lesions may only be present in subjects with abnormal T2WI. 8, 24 The presence of at least 1 Gd-enhancing lesion is predictive of time to CDMS in monofocal, but not in multifocal, presentations.
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The prognostic significance of T1 lesions has been infrequently addressed. Summers et al 4 found that in addition to Gdenhancing lesions, T1 lesions were predictive of cognitive dysfunction after 7 years. Few studies have addressed the association between conventional MR imaging measures and disability. A number of disability scales are used in subjects with CIS. The most frequently used is the Expanded Disability Status Scale (EDSS), which primarily assesses ambulation. 26 Another scale, the Multiple Sclerosis Functional Composite, addresses cognition in addition to mobility. 27, 28 Baseline T2 lesion number is associated with EDSS at long-term follow-up of up to 14 years. 6, 9 A recent study found that baseline Gd-enhancing lesion number was predictive of both EDSS and Multiple Sclerosis Functional Composite at 6 years. The authors also found that while baseline T2 lesion number was not associated with disability, the increase in T2 lesion number over the first year after presentation was predictive of EDSS at 6 years.
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Similar to subjects with MS, lesions are primarily distributed around the ventricular system in subjects with CIS. on the other hand, did not demonstrate either T1 lesion volume or T2LV to be associated with conversion; however, in that study, follow-up was limited to 18 months. T2LV is associated with the development of future disability. An early study by Brex et al 6 found that baseline T2LV was associated with EDSS at 14 years, with the increase in T2LV over the first 5 years also being associated with disability at follow-up. Similarly, other studies have found that the rate of increase in T2LV in the first year is associated with greater long-term disability. 7, 29 T1 lesion volume may be better suited to the prediction of disability scales other than the EDSS. Di Filippo et al 29 found that while baseline T1 lesion volume was not associated with EDSS, it did correlate with Multiple Sclerosis Functional Composite at 6 years. Another study found that both T1 lesion number and volume were predictive of future cognitive dysfunction. 4 Baseline measures of whole-brain volume have not been consistently demonstrated to differentiate subjects with CIS from healthy controls, with a number of studies finding no significant difference at baseline. 22 The corpus callosum is a structure of interest in demyelinating illnesses. In a longitudinal study of 24 subjects with CIS, Audoin et al 62 found that the midsagittal corpus callosal area was significantly reduced at 12 months, when compared with healthy controls. Callosal area also correlated with progression in EDSS. More recently, in a larger cohort of 220 subjects with CIS, change in callosal area in the first 6 months after presentation was predictive of conversion to CDMS by 2 years.
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Diffusion Tensor Imaging
DTI allows assessment of the structural integrity of tissues, with water diffusivity being affected by various CNS tissue barriers, including microtubules and cell membranes. Descriptive parameters include fractional anisotropy, reflective of the fraction of anisotropy along 1 direction, and mean diffusivity or apparent diffusion coefficient, which is the average diffusion per voxel, regardless of direction. In WM, fiber organization is reflected by the anisotropy, with the quantity of anisotropy being augmented by the integrity of surrounding myelin.
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Although histogram analysis of mean diffusivity has been shown to differentiate subjects with CIS from healthy controls, 64 region-of-interest approaches have not. 65 Using tractography, Pagani et al 66 found that subjects with CIS with pyramidal symptoms had increased mean diffusivity in the pyramidal tract, compared with both patients without symptoms, and control subjects. On the other hand, another study found that patients with CIS had increased mean diffusivity in all WM tracts. 67 Neither study found a difference in baseline fractional anisotropy in subjects with CIS. 66, 67 In contrast, another study using tract-based spatial statistics demonstrated widespread reduced fractional anisotropy in the WM of subjects with CIS.
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Tract-based spatial statistics is a recently developed technique that allows analysis of microstructural fiber damage, 68 and may be more sensitive to detect subtle anisotropy changes. However, while baseline fractional anisotropy was correlated with GM atrophy at 1 year in the same cohort, there was no association with disability.
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Magnetization Transfer Imaging
Magnetization transfer imaging measures the transfer of magnetization from hydrogen nuclei of water with restricted motion (bound pool), to hydrogen nuclei of freely moving water (free pool). This allows imaging of the bound pool, which includes protons in macromolecules, including myelin. The magnetization transfer ratio thus represents pathologic changes to macromolecules. 70 Results of studies by using magnetization transfer imaging have been mixed. Iannucci et al 49 found that the magnetization transfer ratio of patients with CIS differed significantly from healthy controls; however, all patients had Ն4 lesions. In a large multicenter study, magnetization transfer ratio differentiated patients from controls in only 1 of 3 study centers. 46 Therefore, magnetization transfer ratio abnormalities are likely associated with increased lesion number at presentation.
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Magnetization transfer ratio has been shown to be predictive of conversion to CDMS 49 and future cognitive decline. 72 Myo-inositol (mIns or Ins) is a metabolite primarily concentrated in glial cells. As with NAA, studies of this metabolite have demonstrated mixed results. In 1 study, when subjects with CIS were compared with controls, baseline mIns of normal-appearing WM discriminated only those who went on to covert to CDMS. 76 On the other hand, another study of a larger cohort found that mIns concentration was higher across the entire CIS group. 75 Metabolite concentrations have a temporal evolution after CIS presentation. Audoin et al 62 performed serial MR spectroscopy, with metabolite concentrations measured in the corpus callosum. They demonstrated baseline reduced NAA and increased choline (Cho, associated with myelin), both of which normalized by 6 months. In another study, the rate of increase in mIns concentration in normal-appearing WM over the first year was predictive of poor executive function at 7.2 years. 4 Although metabolite concentrations may be associated with long-term cognitive change, no single metabolite has demonstrated a correlation with disability, either at baseline or followup. 4 
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Functional MR Imaging
Functional cortical changes are present from the earliest stages of CIS. Compared with healthy controls, subjects with CIS demonstrate increased cortical activation in both cerebral hemispheres, 77, 78 with the extent of activation being related to motor task difficulty. 79 Patterns of activation are associated with shortterm disease evolution, with converters demonstrating recruitment of a more extensive sensorineural network at baseline. 80 In a study assessing cognitive changes in CIS, more widespread activation on fMRI was associated with improved cognition scores, both at baseline and 1-year follow-up. 81 Using a novel fMRI technique called dynamic causal modeling, Rocca et al 82 found that subjects with CIS had increased interconnectivity between the left and right sensorimotor cortex. However, subjects were not followed longitudinally. A recent study measured the amplitude of low frequency alteration in resting-state fMRI. Compared with healthy controls, subjects with CIS demonstrated decreased amplitude of low frequency alteration in numerous cerebral regions. 83 In contrast, subjects with MS have previously been shown to have areas of increased cerebral amplitude of low frequency alteration. 84 The authors hypothesized that amplitude of low frequency alteration may evolve as time passes from the initial presentation.
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MR Imaging Perfusion
Varga et al 85 quantified cerebral blood flow with MR perfusion in a mixed cohort of subjects with CIS and MS. Compared with healthy controls, they found hypoperfusion in the periventricular normal-appearing WM of subjects with CIS. However, none of the perfusion parameters were associated with disability measures in either subgroup.
Brain Iron Quantification
T2 hypointensity, attributable to iron deposition, is a frequent finding in subjects with MS. 86 In subjects with CIS, T2 hypointensity has been identified in the left caudate nucleus. 87 Khalil et al 88 used R2* relaxometry to quantify brain iron deposition in a cohort of subjects with CIS and MS. Compared with subjects with MS, patients with CIS had significantly reduced R2* values in a number of deep GM regions. While R2* values correlated with regional brain volumes, there was no association with disability. 88 In another study, patients with CIS had significantly reduced R2* values in the basal ganglia and thalamus. 89 However, this study was limited, as age was not considered in the methodology, despite control subjects being 3 years older than those with CIS. Hagemeier et al 47 used an SWI phase approach to obtain mean phase of the abnormal phase tissue, a metric for quantification of iron levels. Compared with healthy controls, subjects with CIS had significantly increased abnormal phase and abnormal phase volume in a number of deep GM regions. However, iron deposition was noted in the absence of any significant volume change. In addition to R2* relaxometry, Langkammer et al 90 performed quantitative susceptibility mapping on 26 subjects with CIS. Quantitative susceptibility mapping detects magnetic charge variations attributable not only to iron, but also but also to myelin. Although R2* relaxometry did not differentiate between subjects with CIS and controls, quantitative susceptibility mapping revealed abnormality in the caudate, putamen, and basal ganglia in subjects with CIS. In apparent contrast, a recently published study by Quinn et al 91 showed that subjects with CIS had increased R2* compared with age-matched healthy controls in a number of regions, including the medial thalamus and right putamen. Furthermore, thalamic R2* relaxometry indices were positively correlated with EDSS (r ϭ 0.47, P ϭ .028). Apparently conflicting results by these 2 recently published studies may be attributable to differences in image processing techniques. Langkammer et al 90 
Emerging MR Imaging Technologies
Multicomponent driven equilibrium single pulse observation of T1 and T2 is a newly developed MR imaging technique used to quantify myelin tissue content in vivo. 97 Kitzler et al 98 examined
the utility of multicomponent driven equilibrium single pulse observation for measurement of myelin water fraction across a range of MS subtypes. In subjects with CIS, the total volume of voxels demonstrating deficient myelin water fraction was statistically significant compared with healthy controls. To date, there are no longitudinal studies on subjects with CIS using this technique.
CONCLUSIONS
In subjects presenting with CIS, the primary concern of clinicians and patients is the probability of conversion to CDMS. MR imaging plays a key role in the initial assessment of subjects with CIS. A number of MR imaging markers have demonstrated prognostic potential. Abnormal T2WI is associated with increased risk of conversion. The number and volume of T2 and Gd-enhancing lesions may be predictive of disability. Changes in corpus callosal area and whole-brain volume over the first year from diagnosis of CIS have also shown prognostic utility; however, studies are limited.
Although new and emerging technologies have not demonstrated any convincing prognostic potential at this stage, they do give insight into the mechanisms underlying the pathology of CIS. While regional atrophy is not present at patient presentation, changes in DTI and MR spectroscopy parameters demonstrate that there is functional change occurring in normal-appearing brain tissue. Widespread increased motor cortical activation visualized on fMRI suggests that neuroplasticity is already a factor at initial presentation. Furthermore, subjects with CIS demonstrate brain iron deposition, a feature that is characteristic of MS.
There are a number of limitations within the published liter-ature, and thus, of this review. In general, cohort sizes are small, with heterogeneous subject selection criteria. Many studies are cross-sectional, or have limited length of follow-up. Further studies of robust design and long-term follow-up are needed to investigate the utility of MR imaging techniques in the prediction of disease and disability in subjects with CIS. 
